Gerardo Nigro Selected Research

MD1

1/2013	Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
4/2012	The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.
9/2010	Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study.
9/2009	Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients.
11/2008	Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerardo Nigro Research Topics

Disease

30	Atrial Fibrillation 05/2022 - 09/2010
12	Heart Failure 01/2022 - 08/2009
12	Myotonic Dystrophy (Dystrophia Myotonica) 12/2019 - 11/2008
11	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2009
6	Stroke (Strokes) 11/2020 - 11/2012
5	COVID-19 01/2022 - 01/2020
5	Hemorrhage 11/2020 - 02/2018
4	Tachycardia (Tachyarrhythmias) 01/2022 - 04/2010
4	Sudden Death 12/2021 - 03/2010
3	Morbid Obesity 01/2022 - 01/2020
3	Syncope (Fainting) 01/2022 - 04/2015
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2021 - 02/2015
3	Fibrosis (Cirrhosis) 04/2021 - 01/2009
3	Neoplasms (Cancer) 01/2021 - 06/2018
3	Shock 01/2021 - 01/2018
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2020 - 08/2009
2	Obesity 01/2022 - 11/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Anemia 11/2020 - 01/2019
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2020 - 05/2020
2	Heart Diseases (Heart Disease) 01/2020 - 01/2019
2	X-Linked Emery-Dreifuss Muscular Dystrophy 11/2019 - 03/2010
2	Ventricular Fibrillation 10/2019 - 12/2014
2	Hemolytic Anemia 01/2019 - 07/2016
2	beta-Thalassemia (Cooley's Anemia) 01/2019 - 07/2016
2	Muscular Diseases (Myopathy) 01/2019 - 05/2015
2	Vasovagal Syncope 01/2018 - 11/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Infections 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Atrial Flutter (Flutter, Atrial) 01/2022
1	Brugada Syndrome 10/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2021
1	Venous Thromboembolism 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Unconsciousness (Loss of Consciousness) 01/2021
1	Body Weight (Weight, Body) 11/2020
1	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2020
1	Diabetes Mellitus 05/2020
1	Torsades de Pointes (Torsade de Pointes) 01/2020
1	Protein Deficiency 01/2019
1	Siderosis 01/2019
1	Acute Coronary Syndrome 01/2019
1	Ischemic Stroke 01/2019
1	Embolic Stroke 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Death (Near-Death Experience) 01/2019

Drug/Important Bio-Agent (IBA)

16	AnticoagulantsIBA 05/2022 - 11/2012
13	Vitamin K FDA Link 10/2021 - 06/2018
5	edoxabanIBA 10/2021 - 01/2019
5	MD1IBA 01/2013 - 11/2008
3	N(4)-oleylcytosine arabinosideIBA 11/2020 - 06/2018
3	apixabanIBA 01/2020 - 02/2017
3	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 02/2017
3	Dabigatran FDA Link 01/2019 - 02/2017
3	RivaroxabanIBA 02/2018 - 12/2016
3	Sarcoglycans (beta Sarcoglycan)IBA 04/2013 - 01/2009
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 04/2015
2	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021 - 04/2020
2	Pharmaceutical PreparationsIBA 10/2021 - 01/2020
2	Dichlorodiphenyldichloroethane (DDD)IBA 01/2021 - 01/2018
2	MB Form Creatine KinaseIBA 12/2019 - 01/2018
2	Troponin IIBA 12/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 12/2019 - 01/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2019 - 01/2018
2	GlobinsIBA 01/2019 - 07/2016
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 07/2016
2	IronIBA 01/2019 - 07/2016
1	PCSK9 InhibitorsIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	DiureticsIBA 01/2022
1	sacubitrilIBA 12/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2020
1	Enalapril FDA LinkGeneric 04/2020
1	CreatinineIBA 03/2020
1	Lopinavir FDA Link 01/2020
1	Cardiovascular AgentsIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 11/2019
1	beta-Globins (beta Globin)IBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	DystrophinIBA 01/2019

Therapy/Procedure

24	Therapeutics 01/2022 - 12/2013
8	Electric Countershock (Cardioversion) 10/2021 - 12/2016
7	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2021 - 01/2018
7	Cardiac Resynchronization Therapy 12/2021 - 08/2009
5	Defibrillators (Defibrillator) 12/2021 - 03/2010
3	Catheter Ablation 01/2022 - 04/2010
1	Heart-Assist Devices 01/2022
1	Patient Readmission 01/2022
1	Continuity of Patient Care 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Stents 01/2019
1	Heart Transplantation (Grafting, Heart) 01/2019